Regulations.gov document
Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In…
Other · FDA-2016-D-1270 · posted Jul 14, 2016
Key facts
| Document ID | FDA-2016-D-1270-0002 |
|---|---|
| Title | Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases Draft Guidance for Stakeholders and Food and Drug Administration Staff |
| Document type | Other |
| Subtype | Guidance |
| Agency | FDA |
| Docket | FDA-2016-D-1270 |
| Posted | Jul 14, 2016 |
| Comment period opens | Jul 14, 2016 |
| Comments due | Oct 7, 2016 |
At a glance
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: